Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Is aspirin safe for patients with heart failure?

Literature DB >> 7547012

Is aspirin safe for patients with heart failure?

J G Cleland¹, C J Bulpitt, R H Falk, I N Findlay, C M Oakley, G Murray, P A Poole-Wilson, C R Prentice, G C Sutton.
1. Western Infirmary, Glasgow.

Abstract

Entities: Chemical Disease Species

Mesh：

Substances：

Year: 1995 PMID： 7547012 PMCID： PMC484008 DOI： 10.1136/hrt.74.3.215

Source DB: PubMed Journal: Br Heart J ISSN： 0007-0769

× No keyword cloud information.

39 in total

Review 1. The clinical course of heart failure and its modification by ACE inhibitors: insights from recent clinical trials.

Authors: J G Cleland
Journal: Eur Heart J Date: 1994-01 Impact factor: 29.983

2. Low incidence of stroke in ambulatory patients with heart failure: a prospective study.

Authors: S D Katz; P R Marantz; L Biasucci; G Jondeau; K Lee; C Brennan; T H LeJemtel
Journal: Am Heart J Date: 1993-07 Impact factor: 4.749

3. Effect of enalapril on myocardial infarction and unstable angina in patients with low ejection fractions.

Authors: S Yusuf; C J Pepine; C Garces; H Pouleur; D Salem; J Kostis; C Benedict; M Rousseau; M Bourassa; B Pitt
Journal: Lancet Date: 1992-11-14 Impact factor: 79.321

4. Renal response to indomethacin in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.

Authors: S S Gottlieb; S Robinson; C M Krichten; M L Fisher
Journal: Am J Cardiol Date: 1992-10-01 Impact factor: 2.778

5. Platelet function, thrombin and fibrinolytic activity in patients with heart failure.

Authors: S M Jafri; T Ozawa; E Mammen; T B Levine; C Johnson; S Goldstein
Journal: Eur Heart J Date: 1993-02 Impact factor: 29.983

6. Relationship between hemostatic abnormalities and neuroendocrine activity in heart failure.

Authors: E Sbarouni; A Bradshaw; F Andreotti; E Tuddenham; C M Oakley; J G Cleland
Journal: Am Heart J Date: 1994-03 Impact factor: 4.749

7. Fat-suppressed breath-hold magnetic resonance coronary angiography.

Authors: W J Manning; W Li; N G Boyle; R R Edelman
Journal: Circulation Date: 1993-01 Impact factor: 29.690

8. Combined effect of captopril and aspirin in renal hemodynamics in elderly patients with congestive heart failure.

Authors: D Schwartz; R Kornowski; H Lehrman; M Averbuch; A Pines; M Greenland; A Finkelstein; Y Levo
Journal: Cardiology Date: 1992 Impact factor: 1.869

9. Effects of acetylsalicylic acid on peripheral hemodynamics in patients with chronic heart failure treated with angiotensin-converting enzyme inhibitors.

Authors: J van Wijngaarden; A J Smit; P A de Graeff; W H van Gilst; S A van der Broek; D J van Veldhuisen; K I Lie; H Wesseling
Journal: J Cardiovasc Pharmacol Date: 1994-02 Impact factor: 3.105

10. Double-blind trial of aspirin in primary prevention of myocardial infarction in patients with stable chronic angina pectoris. The Swedish Angina Pectoris Aspirin Trial (SAPAT) Group.

Authors: S Juul-Möller; N Edvardsson; B Jahnmatz; A Rosén; S Sørensen; R Omblus
Journal: Lancet Date: 1992-12-12 Impact factor: 79.321

17 in total

Review 1. Heart failure: Part II.

Authors: M S Wilkes; H Middlekauff; J R Hoffman
Journal: West J Med Date: 1999-06

10. Effect of aspirin on vasodilation to bradykinin and substance P in patients with heart failure treated with ACE inhibitor.

Authors: Andrew P Davie; John J V McMurray
Journal: Br J Clin Pharmacol Date: 2002-01 Impact factor: 4.335

Is aspirin safe for patients with heart failure?

Review 1. The clinical course of heart failure and its modification by ACE inhibitors: insights from recent clinical trials.

2. Low incidence of stroke in ambulatory patients with heart failure: a prospective study.

3. Effect of enalapril on myocardial infarction and unstable angina in patients with low ejection fractions.

4. Renal response to indomethacin in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.

5. Platelet function, thrombin and fibrinolytic activity in patients with heart failure.

6. Relationship between hemostatic abnormalities and neuroendocrine activity in heart failure.

7. Fat-suppressed breath-hold magnetic resonance coronary angiography.

8. Combined effect of captopril and aspirin in renal hemodynamics in elderly patients with congestive heart failure.

9. Effects of acetylsalicylic acid on peripheral hemodynamics in patients with chronic heart failure treated with angiotensin-converting enzyme inhibitors.

10. Double-blind trial of aspirin in primary prevention of myocardial infarction in patients with stable chronic angina pectoris. The Swedish Angina Pectoris Aspirin Trial (SAPAT) Group.

Review 1. Heart failure: Part II.

2. Preventing atherosclerotic events with aspirin.

3. Chronic aspirin is effective--if data are massaged sufficiently.

Review 4. Aspirin and ACE-inhibitors: for wedding or funeral?

Review 5. Optimal treatment of heart failure in the elderly.

6. Is aspirin safe for patients with heart failure?

7. Is aspirin safe in heart failure? more data.

Review 8. Neuroendocrine activation after myocardial infarction: causes and consequences.

Review 9. Intracardiac thrombus formation in cardiac impairment: the role of anticoagulant therapy.

10. Effect of aspirin on vasodilation to bradykinin and substance P in patients with heart failure treated with ACE inhibitor.